Loading…
TELA Bio, Inc. is projected to decline to $0.695 by 2027, a -6% move from its current price of $0.74. TELA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7094 | $0.7397 | $0.7714 | -0.03% |
| Aug 6 | $0.6969 | $0.7395 | $0.7847 | -0.07% |
| Aug 7 | $0.6875 | $0.7392 | $0.7949 | -0.10% |
| Aug 8 | $0.6795 | $0.739 | $0.8036 | -0.14% |
| Aug 9 | $0.6726 | $0.7387 | $0.8113 | -0.17% |
| Aug 10 | $0.6664 | $0.7385 | $0.8183 | -0.21% |
| Aug 11 | $0.6607 | $0.7382 | $0.8248 | -0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6607 | $0.7382 | $0.8248 | -0.24% |
| Week 2 | $0.6295 | $0.7364 | $0.8615 | -0.48% |
| Week 3 | $0.6062 | $0.7346 | $0.8903 | -0.72% |
| Week 4 | $0.587 | $0.7329 | $0.9149 | -0.96% |
| Week 5 | $0.5705 | $0.7311 | $0.9369 | -1.20% |
| Week 6 | $0.5558 | $0.7293 | $0.957 | -1.44% |
| Week 7 | $0.5425 | $0.7276 | $0.9757 | -1.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TELA Bio, Inc. is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions. Its product portfolio includes OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction, OviTex PRS Reinforced Tissue Matrix products for plastic and reconstructive surgery, and OviTex for Laparoscopic and Robotic Procedures.
These sterile reinforced tissue matrices are designed to be used in laparoscopic and robotic-assisted hernia repairs and are derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid. The company markets its products through a single direct sales force, principally in the United States. TEL A Bio, Inc.
was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio, Inc. (TELA) is a healthcare company with a current price of $0.7098 and a market cap of $31.78M, ranking 4457 by market capitalization. The near-term price outlook aligns with a neutral stance, while longer-term forecasts indicate potential upside as the years unfold.
The current price sits at a level comparable to the 2026 forecast avg, with a wide-range path projected across the following years.
A major floor 30.5% below — a decisive break under it would weaken the trend.
The nearest floor, 12.2% below — buyers have tended to step in here.
The nearest ceiling, 20.8% above — a clean break opens room to run.
A major ceiling 52.7% above — clearing it would confirm fresh momentum.
Key TELA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TELA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6876 | Buy | $0.7048 | Buy |
| MA 10 | $0.7013 | Buy | $0.7105 | Buy |
| MA 20 | $0.7516 | Sell | $0.7342 | Buy |
| MA 50 | $0.8069 | Sell | $0.7792 | Sell |
| MA 100 | $0.79 | Sell | $0.8298 | Sell |
| MA 200 | $0.9377 | Sell | $1.02 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.62 | Neutral |
| Stoch RSI (14) | 99.64 | Sell |
| CCI (20) | -27.47 | Neutral |
| Williams %R (14) | -40.74 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -7.01 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 59.26 | Neutral |
| TRIX (15) | -0.59 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 45.22 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 0.70 | Buy |
| ADX (14) | 12.88 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture shows a bearish sentiment with RSI(14) at 50 and key moving averages at SMA50 of $0.8095 and SMA200 of $0.9416. Immediate support is at $0.65 and resistance at $0.894, framing a near-term trading band. The 30-day range spans from $0.5355 to $0.9409, reflecting modest volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.56 | $0.74 | $0.9182 | 0% | Neutral | |
| $0.5275 | $0.695 | $0.9825 | -6% | Neutral | |
| $0.5567 | $0.768 | $1.15 | +4% | Neutral | |
| $0.4775 | $0.6847 | $1.06 | -7% | Neutral | |
| $0.5693 | $0.845 | $1.36 | +14% | Neutral | |
| $0.7407 | $1.14 | $1.88 | +53% | Bullish | |
| $0.6839 | $1.08 | $1.84 | +46% | Bullish | |
| $0.6844 | $1.11 | $1.94 | +50% | Bullish | |
| $0.6694 | $1.12 | $1.99 | +51% | Bullish | |
| $0.5951 | $1.02 | $1.85 | +38% | Bullish | |
| $0.8802 | $1.71 | $3.37 | +131% | Bullish | |
| $1.10 | $2.45 | $5.43 | +231% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.56 | $0.74 | $0.8685 | +0.00% |
| September 2026 | $0.5752 | $0.6906 | $0.8598 | -6.68% |
| October 2026 | $0.5908 | $0.717 | $0.9072 | +3.82% |
| November 2026 | $0.5941 | $0.7275 | $0.9325 | +1.46% |
| December 2026 | $0.5736 | $0.7081 | $0.9182 | -2.67% |
Click any year to see its month-by-month TELA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
TELA Bio, Inc.'s 2026 outlook centres on $0.74, within a $0.56 to $0.9182 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TELA could reach as high as $0.9825, with a base case around $0.695 and support toward $0.5275 — roughly -6% from $0.74. Price action looks broadly range-bound.
Expect TELA to range from $0.5567 to $1.15 through 2028. The $0.768 average target implies a +4% move from current prices. That is up +11% on the projected 2027 average. A consolidation phase looks the most probable path here.
The TELA price prediction for 2029 points to an average of $0.6847 (low $0.4775, high $1.06) — a potential decline of -7% on today's $0.74. Price action looks broadly range-bound.
In 2030, TELA is projected to trade between $0.5693 and $1.36, averaging $0.845 — a potential gain of +14% from today's $0.74. That is up +23% on the projected 2029 average. A consolidation phase looks the most probable path here.
TELA Bio, Inc.'s 2031 outlook centres on $1.14, within a $0.7407 to $1.88 range. That is up +34% on the projected 2030 average. That marks a +53% change versus current levels. Momentum favours further upside here.
By 2032, TELA could reach as high as $1.84, with a base case around $1.08 and support toward $0.6839 — roughly +46% from $0.74. Buyers look set to stay in control over this stretch.
Expect TELA to range from $0.6844 to $1.94 through 2033. The $1.11 average target implies a +50% move from current prices. That is up +3% on the projected 2032 average. Momentum favours further upside here.
The TELA price prediction for 2034 points to an average of $1.12 (low $0.6694, high $1.99) — a potential gain of +51% on today's $0.74. Buyers look set to stay in control over this stretch.
In 2035, TELA is projected to trade between $0.5951 and $1.85, averaging $1.02 — a potential gain of +38% from today's $0.74. That is -9% versus the projected 2034 average. Momentum favours further upside here.
TELA Bio, Inc.'s 2040 outlook centres on $1.71, within a $0.8802 to $3.37 range. That is up +67% on the projected 2035 average. That marks a +131% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TELA could reach as high as $5.43, with a base case around $2.45 and support toward $1.10 — roughly +231% from $0.74. Momentum favours further upside here.
Investing $1,000 in TELA today (≈ 1,351.351351 TELA) could be worth
$3,314.67
+$2,314.67 (+231%) by 2050 · US Dollar
Based on the average projected TELA price of $2.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TELAwould be worth at today's price.
$1,000 invested in TELA on Jul 31, 2025 (≈ 588.235278 TELA) would be worth
$435.29
-$564.71 (-56.5%) today · 0.44× · US Dollar
Based on a TELA entry price of $1.7 vs. today's $0.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.691 | $1,070.91 | +7.1% |
| 1 month ago | $0.72 | $1,027.78 | +2.8% |
| 3 months ago | $0.989 | $748.23 | -25.2% |
| 6 months ago | $0.945 | $783.07 | -21.7% |
| 1 year ago | $1.7 | $435.29 | -56.5% |
| All time (5.0y) ago | $13.8 | $53.62 | -94.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TELA forecast.
Our base-case forecast reaches $1.50 around 2040.
Implied market cap at $1.50: $67.15M
In 2026, the avg price is $0.7098 with a min of $0.56 and a max of $0.8828, and a neutral sentiment. The outlook strengthens into 2030 with an avg of $0.829 and a 16.8% ROI, remaining neutral. Beyond 2030, the forecast turns bullish, with 2031 at an avg of $1.11 and a max of $1.85 (ROI 56), 2032 at $1.05 (ROI 47.5), 2033 at $1.09 (ROI 52.9), 2034 at $1.09 (ROI 53.1), and 2035 at $0.9883 (ROI 39.2).
The 2040 forecast shows an avg of $1.67 with a max of $3.31 and ROI of 134.6, and the 2050 forecast projects an avg of $2.41 with a max of $5.40 and ROI of 240. Overall, the long-term path suggests meaningful upside with bullish sentiment in the later years, but these are estimates and not guarantees.
Tap a question to reveal the answer.
Forecasts show min $0.5551, avg $0.829, max $1.34 with ROI 16.8% and sentiment NEUTRAL.
For 2026 the forecast is min $0.56, avg $0.7098, max $0.8828 with ROI 0 and sentiment NEUTRAL.
The 2031 forecast lists min $0.7175, avg $1.11, max $1.85 with ROI 56 and sentiment BULLISH.
The 2040 forecast is min $0.8459, avg $1.67, max $3.31 with ROI 134.6 and sentiment BULLISH.
The 2050 forecast is min $1.09, avg $2.41, max $5.40 with ROI 240 and sentiment BULLISH.
TELA Bio, Inc. Community Discussion
0Share your TELA Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.